Appropriateness of Angioplasty in Patients With Chronic Coronary Syndromes

Recruiting Observational Study
Coronary Artery Disease Angina Pectoris
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,875 (estimated)
Sponsor
University of Sao Paulo General Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Percutaneous coronary intervention (PCI) has dramatically changed the treatment of obstructive coronary artery disease patients. PCI is indicated in patients with chronic coronary syndrome (CCS) symptoms unresponsive to optimized medical therapy. The American College of Cardiology Foundation and partners developed in 2009 - and updated them in May 2017 - the appropriateness criteria for PCI to sup…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All patients within the age range who underwent elective PCI defined as a procedure indicated in an outpatient scenario or an inpatient in a non-acute setting when the Heart Team was called to evaluate the patient and agreed with the indication for PCI Exclusion Criteria: * …
Contacts

Luis Henrique W Gowdak, MD, PhD

551126614326

luis.gowdak@incor.usp.br

CONTACT

Sara DV Ziotti, MD

551126614326

sara.ziotti@usp.br

CONTACT